Literature DB >> 16025740

Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients.

Akira Kurata1, Yuji Shigematsu, Jitsuo Higaki.   

Abstract

Both hyperuricemia and echocardiographically determined left ventricular (LV) mass have a well-determined association with cardiovascular morbidity and mortality. However, whether or not there is a sex difference in the association of serum uric acid level with LV mass has never been systematically explored. We examined the sex-specific relation of serum uric acid level and echocardiographic indexes of LV structure in never-treated patients with essential hypertension. We enrolled 160 never-treated hypertensive patients (89 men and 71 women) to assess the possible relationship between LV mass and serum uric acid levels. LV measurements were performed according to the recommendations of the American Society of Echocardiography and the Penn Convention. LV mass was indexed by height, body surface area and height raised to the 2.7th power. A positive significant correlation between LV geometry (LV mass, indexed LV mass and relative wall thickness) and serum uric acid level was found in male hypertensive patients but not in female hypertensive patients. Independent determinants of serum uric acid levels in male hypertensive patients were LV mass and serum creatinine levels. In addition, male hypertensive patients with concentric hypertrophy showed the highest serum uric acid levels. In comparison, independent determinants of serum uric acid levels in female hypertensive patients were age and serum creatinine levels. In conclusion, these findings indicate a sex difference in the association of uric acid with LV geometry in Japanese hypertensive patients. In addition, the finding that the highest levels of serum uric acid were observed in our male hypertensive patients with concentric hypertrophy confirmed the previous reports that these patients have the highest risk for cardiovascular morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025740     DOI: 10.1291/hypres.28.133

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

2.  Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.

Authors:  Y Lin; X Lai; G Chen; Y Xu; B Huang; Y Wu; Z Chen; L Yao; F Lin; Y Qiao; Z Chen; S Zhu; H Huang; J Wen
Journal:  J Endocrinol Invest       Date:  2011-05-30       Impact factor: 4.256

Review 3.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

4.  Hyperuricemia and its association with carotid intima-media thickness in hypertensive and non hypertensive patients.

Authors:  Abdelhakem Selem Elsayed; Mansour Mohamad Mostafa; Alshazly Abdelkhalik; Mohey Eldeen A Eldeeb; Mohammed Shafee Abdulgani
Journal:  J Saudi Heart Assoc       Date:  2010-03-10

5.  Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.

Authors:  Brian J DeBosch; Oliver Kluth; Hideji Fujiwara; Annette Schürmann; Kelle Moley
Journal:  Nat Commun       Date:  2014-08-07       Impact factor: 14.919

6.  Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Changlin Zhang; Rong Liu; Jiansong Yuan; Jingang Cui; Fenghuan Hu; Weixian Yang; Yan Zhang; Chengzhi Yang; Shubin Qiao
Journal:  Biol Sex Differ       Date:  2016-04-05       Impact factor: 5.027

7.  Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease.

Authors:  Chuchu Zeng; Dongsheng Cheng; Xiaohua Sheng; Guihua Jian; Ying Fan; Yuqiang Chen; Junhui Li; Hongda Bao; Niansong Wang
Journal:  J Diabetes Res       Date:  2017-06-20       Impact factor: 4.011

8.  MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.

Authors:  Xue Li; Xiangrui Meng; Athina Spiliopoulou; Maria Timofeeva; Wei-Qi Wei; Aliya Gifford; Xia Shen; Yazhou He; Tim Varley; Paul McKeigue; Ioanna Tzoulaki; Alan F Wright; Peter Joshi; Joshua C Denny; Harry Campbell; Evropi Theodoratou
Journal:  Ann Rheum Dis       Date:  2018-02-06       Impact factor: 19.103

9.  A Profile of Renal Function in Northern Cameroonians with Essential Hypertension.

Authors:  Marcel Tangyi Tamanji; Divine Amagho Ngwakum; Olivier Pancha Mbouemboue
Journal:  Cardiorenal Med       Date:  2017-08-17       Impact factor: 2.041

10.  Mannose binding lectin and macrophage migration inhibitory factor gene polymorphisms in Turkish children with cardiomyopathy: no association with MBL2 codon 54 A/B genotype, but an association between MIF -173 CC genotype.

Authors:  Nilgun Col-Araz; Sibel Oguzkan-Balci; Osman Baspinar; Tugce Sever; Ayse Balat; Sacide Pehlivan
Journal:  Int J Med Sci       Date:  2012-08-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.